tiprankstipranks
Advertisement
Advertisement

AUPH Stock Latest News

Aurinia Pharmaceuticals reports Q1 EPS 25c, consensus 20c
The FlyAurinia Pharmaceuticals reports Q1 EPS 25c, consensus 20c
48m ago
AUPH
Aurinia backs FY26 revenue view $315M-$325M, consensus $326.22M
PremiumThe Fly
Aurinia backs FY26 revenue view $315M-$325M, consensus $326.22M
51m ago
AUPH
Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline
PremiumCompany Announcements
Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline
1M ago
8K
AUPH
Kezar Life Sciences takeover valuation ‘makes sense,’ says Jefferies
PremiumThe Fly
Kezar Life Sciences takeover valuation ‘makes sense,’ says Jefferies
1M ago
KZR
AUPH
Midday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane
PremiumThe Fly
Midday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane
1M ago
IQ
SR
Aurinia to Buy Kezar Life Sciences in Cash-and-CVR Autoimmune Deal
PremiumCompany AnnouncementsAurinia to Buy Kezar Life Sciences in Cash-and-CVR Autoimmune Deal
1M ago
AUPH
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
Premium
The Fly
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
1M ago
KZR
AUPH
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
Premium
The Fly
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
1M ago
KZR
AUPH
Aurinia Reshapes C-Suite as Investor Kevin Tang Takes CEO Role Without Pay
PremiumCompany Announcements
Aurinia Reshapes C-Suite as Investor Kevin Tang Takes CEO Role Without Pay
1M ago
AUPH
MKT Capital ‘applauds’ Aurinia’s management transition
PremiumThe Fly
MKT Capital ‘applauds’ Aurinia’s management transition
1M ago
AUPH
Aurinia Reshapes Executive Team as Board Chair Kevin Tang Becomes CEO
PremiumCompany Announcements
Aurinia Reshapes Executive Team as Board Chair Kevin Tang Becomes CEO
2M ago
AUPH
Aurinia Pharmaceuticals announces Tang to succeed Greenleaf as CEO
PremiumThe Fly
Aurinia Pharmaceuticals announces Tang to succeed Greenleaf as CEO
2M ago
AUPH
Aurinia Pharmaceuticals Earnings Call Highlights Growth And Risks
PremiumCompany AnnouncementsAurinia Pharmaceuticals Earnings Call Highlights Growth And Risks
2M ago
AUPH
Aurinia Lifts Profits on LUPKYNIS Growth and Sets Double-Digit 2026 Revenue Outlook
Premium
Company Announcements
Aurinia Lifts Profits on LUPKYNIS Growth and Sets Double-Digit 2026 Revenue Outlook
2M ago
AUPH
Aurinia Lifts Revenue on LUPKYNIS Growth, Sets Strong 2026 Sales Outlook
Premium
Company Announcements
Aurinia Lifts Revenue on LUPKYNIS Growth, Sets Strong 2026 Sales Outlook
2M ago
AUPH
Aurinia Pharmaceuticals reports Q4 EPS $1.53, consensus 22c
PremiumThe Fly
Aurinia Pharmaceuticals reports Q4 EPS $1.53, consensus 22c
2M ago
AUPH
Aurinia Pharmaceuticals sees 2026 revenue $315M-$-325M, consensus $326.8M
PremiumThe Fly
Aurinia Pharmaceuticals sees 2026 revenue $315M-$-325M, consensus $326.8M
2M ago
AUPH
AUPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
AUPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
AUPH
Aurinia Sets February 26 Date to Report 2025 Results and Business Update
PremiumCompany Announcements
Aurinia Sets February 26 Date to Report 2025 Results and Business Update
3M ago
AUPH
Aurinia Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
PremiumThe FlyAurinia Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
5M ago
AUPH
Aurinia Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Aurinia Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
5M ago
AUPH
Aurinia Pharmaceuticals upgraded to Buy from Hold at Jefferies
Premium
The Fly
Aurinia Pharmaceuticals upgraded to Buy from Hold at Jefferies
6M ago
AUPH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >